Effect of ioxaglate--an ionic low osmolar contrast medium--on fibrin polymerization in vitro
- PMID: 8292718
Effect of ioxaglate--an ionic low osmolar contrast medium--on fibrin polymerization in vitro
Abstract
Ioxaglate, an iodinated contrast agent, decreases the rates of fibrin clot formation induced by thrombin or reptilase. This effect is not related to an increase in the ionic strength of the medium since a specific control of equivalent composition does not induce such variation. The concentration of ioxaglate which led to a 50% decrease of the control clot turbidity induced by thrombin was 17.5 +/- 2 mM. Macroscopically, clots formed with ioxaglate were larger and less turbid than the isotonic control. An increase in fibrin fibre diameters and a decrease in their densities were observed. During the fibrin polymerization process, all the fibrinogen was converted into fibrin, as for both the control and ioxaglate quantitative analysis of clots and supernatants showed (1) an identical quantity of FpA in clot supernatants, (2) the same quantities of protein incorporated into clots, and (3) no trace of fibrin monomers in the clot supernatants. Furthermore, dissolution in urea of clots formed in the presence of ioxaglate occurred more rapidly than in the control. Total incorporation of fibrinogen into clots, associated with a decrease in clot turbidity, indicated the existence of a qualitative abnormality in the construction of the three-dimensional fibrin structure. Using differential scanning calorimetry, it was observed that the two domains (D and E) of fibrinogen were modified by ioxaglate, showing the absence of specificity in the interaction between ioxaglate and a particular domain.
Similar articles
-
Release of fibrinopeptides by the slow and fast forms of thrombin.Biochemistry. 1996 Apr 9;35(14):4417-26. doi: 10.1021/bi952834d. Biochemistry. 1996. PMID: 8605191
-
Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.Blood Coagul Fibrinolysis. 1993 Oct;4(5):721-7. Blood Coagul Fibrinolysis. 1993. PMID: 8292721
-
Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.Blood Coagul Fibrinolysis. 2007 Dec;18(8):731-7. doi: 10.1097/MBC.0b013e3282f10157. Blood Coagul Fibrinolysis. 2007. PMID: 17982313
-
Thrombin generation and fibrin clot structure.Blood Rev. 2007 May;21(3):131-42. doi: 10.1016/j.blre.2006.11.001. Epub 2007 Jan 8. Blood Rev. 2007. PMID: 17208341 Review.
-
Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.Blood Coagul Fibrinolysis. 1997 Jul;8(5):257-67. Blood Coagul Fibrinolysis. 1997. PMID: 9282789 Review.
Cited by
-
Angioplasty with Stenting in Acute Coronary Syndromes with Very Low Contrast Volume Using 6F Diagnostic Catheters and Bench Testing of Catheters.Open Access Maced J Med Sci. 2019 Mar 29;7(6):1004-1012. doi: 10.3889/oamjms.2019.238. eCollection 2019 Mar 30. Open Access Maced J Med Sci. 2019. PMID: 30976350 Free PMC article.
-
The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.Catheter Cardiovasc Interv. 2016 Nov;88(5):727-737. doi: 10.1002/ccd.26353. Epub 2016 Jan 16. Catheter Cardiovasc Interv. 2016. PMID: 26773574 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources